Literature DB >> 28575229

The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident CVD in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD-MIND Study.

Tali Cukierman-Yaffe1,2,3, Hertzel C Gerstein3, Michael E Miller4, Lenore J Launer5, Jeff D Williamson6, Karen R Horowitz7,8, Faramarz Ismail-Beigi7,8, Ronald M Lazar9.   

Abstract

Context and Objective: Diabetes is associated with a greater risk for incident cardiovascular disease and cognitive dysfunction. This study aimed to investigate, in people with type 2 diabetes, the association of a simple measure of cognitive function to cardiovascular disease events and mortality. Design, Setting, Participants, Measurements, and Outcomes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial included persons with longstanding type 2 diabetes. A substudy of 2977 (Memory in Diabetes) participants aged 55 years or older aimed to test the effect of the interventions on brain structure and function. At baseline, participants were administered a cognitive battery that included the digit symbol substitution test (DSST). The associations of the DSST and the ACCORD primary outcome (the first occurrence of nonfatal myocardial infarction or nonfatal stroke or death from cardiovascular causes) and all-cause mortality were investigated with Cox proportional hazard models adjusting for several demographic and clinical variables.
Results: Median follow-up time was 4.27 years. An inverse relationship between the incidence of the ACCORD primary outcome and baseline cognitive score was demonstrated. A 1-point higher DSST score was associated with a lower incidence of the primary outcome (hazard ratio, 0.987; 95% confidence interval, 0.977 to 0.998; P = 0.019), after adjustment for demographic and clinical trial factors, additional baseline cardiovascular risk factors, and self-reported need for assistance to follow the protocol.
Conclusion: Lower scores on the DSST, a simple, sensitive neuropsychological instrument, are associated with a higher incidence of cardiovascular events in persons >55 years old with longstanding diabetes.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Year:  2017        PMID: 28575229      PMCID: PMC5587069          DOI: 10.1210/jc.2016-3480

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults.

Authors:  Caterina Rosano; Anne B Newman; Ronit Katz; Calvin H Hirsch; Lewis H Kuller
Journal:  J Am Geriatr Soc       Date:  2008-08-05       Impact factor: 5.562

Review 2.  Sweet memories: 20 years of progress in research on cognitive functioning in diabetes.

Authors:  Geert Jan Biessels
Journal:  Eur J Pharmacol       Date:  2013-07-17       Impact factor: 4.432

3.  Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.

Authors:  E W Gregg; K Yaffe; J A Cauley; D B Rolka; T L Blackwell; K M Narayan; S R Cummings
Journal:  Arch Intern Med       Date:  2000-01-24

4.  Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women.

Authors:  K Yaffe; T Blackwell; R A Whitmer; K Krueger; E Barrett Connor
Journal:  J Nutr Health Aging       Date:  2006 Jul-Aug       Impact factor: 4.075

5.  Cognitive impairment and risk of cardiovascular events and mortality.

Authors:  Martin O'Donnell; Koon Teo; Peggy Gao; Craig Anderson; Peter Sleight; Antonio Dans; Irene Marzona; Jackie Bosch; Jeff Probstfield; Salim Yusuf
Journal:  Eur Heart J       Date:  2012-05-02       Impact factor: 29.983

6.  Brain Volume as an Integrated Marker for the Risk of Death in a Community-Based Sample: Age Gene/Environment Susceptibility--Reykjavik Study.

Authors:  Saskia S G C Van Elderen; Qian Zhang; Sigudur Sigurdsson; Thaddeus J Haight; Oscar Lopez; Gudny Eiriksdottir; Palmi Jonsson; Laura de Jong; Tamara B Harris; Melissa Garcia; Vilmundar Gudnason; Mark A van Buchem; Lenore J Launer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-10-30       Impact factor: 6.053

7.  Performance on the digit symbol substitution test and 5-year mortality in the Western Collaborative Group Study.

Authors:  G E Swan; D Carmelli; A LaRue
Journal:  Am J Epidemiol       Date:  1995-01-01       Impact factor: 4.897

8.  Relation between cognitive function and mortality in middle-aged adults: the atherosclerosis risk in communities study.

Authors:  Valory N Pavlik; Suzana Alves de Moraes; Moyses Szklo; David S Knopman; Thomas H Mosley; David J Hyman
Journal:  Am J Epidemiol       Date:  2003-02-15       Impact factor: 4.897

9.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

10.  Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial.

Authors:  Zubin Punthakee; Michael E Miller; Lenore J Launer; Jeff D Williamson; Ronald M Lazar; Tali Cukierman-Yaffee; Elizabeth R Seaquist; Faramarz Ismail-Beigi; Mark D Sullivan; Laura C Lovato; Richard M Bergenstal; Hertzel C Gerstein
Journal:  Diabetes Care       Date:  2012-02-28       Impact factor: 19.112

View more
  5 in total

1.  People with type 2 diabetes and screen-detected cognitive impairment use acute health care services more often: observations from the COG-ID study.

Authors:  Jolien Janssen; Paula S Koekkoek; Geert Jan Biessels; L Jaap Kappelle; Guy E H M Rutten
Journal:  Diabetol Metab Syndr       Date:  2019-02-22       Impact factor: 3.320

2.  Association between diabetes and cognitive function at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil).

Authors:  Mônica M Teixeira; Valéria M A Passos; Sandhi M Barreto; Maria I Schmidt; Bruce B Duncan; Alline M R Beleigoli; Maria J M Fonseca; Pedro G Vidigal; Larissa F Araújo; Maria de Fátima H S Diniz
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

3.  Lowered cognitive function and the risk of the first events of cardiovascular diseases: findings from a cohort study in Lithuania.

Authors:  Dalia Luksiene; Laura Sapranaviciute-Zabazlajeva; Abdonas Tamosiunas; Ricardas Radisauskas; Martin Bobak
Journal:  BMC Public Health       Date:  2021-04-24       Impact factor: 3.295

4.  Relationship between cognitive function in individuals with diabetic foot ulcer and mortality.

Authors:  Yael Sela; Keren Grinberg; Tali Cukierman-Yaffe; Rachel Natovich
Journal:  Diabetol Metab Syndr       Date:  2022-09-19       Impact factor: 5.395

5.  Cognitive Function and Mortality: Results from Kaunas HAPIEE Study 2006-2017.

Authors:  Abdonas Tamosiunas; Laura Sapranaviciute-Zabazlajeva; Dalia Luksiene; Dalia Virviciute; Martin Bobak
Journal:  Int J Environ Res Public Health       Date:  2020-04-01       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.